119-S-3812 Journalist Public Summary
119 · S 3812 WORK to Save Lives Act
Bipartisan bill directing OSHA to issue nonbinding guidance for private employers and binding rules for federal agencies to keep opioid overdose reversal medication on hand and train workers annually; it has held a Senate HELP Committee hearing (March 19, 2026) and remains in committee.
Headline Summary
A bipartisan Senate bill would put overdose-reversal medication and basic training into more workplaces—mandatory for federal agencies, advisory for private employers.
What It Does
The WORK to Save Lives Act (S. 3812) tells the Labor Department’s Occupational Safety and Health Administration (OSHA) to do two things. First, publish non-mandatory guidance for private employers on stocking opioid overdose reversal medication and giving employees annual training. Second, issue regulations requiring federal agencies to stock the medication and provide annual training. OSHA would have 270 days after the bill becomes law to issue both the guidance and the federal-agency rules.
- Scope: “Employer” follows the Occupational Safety and Health Act definition, but the U.S. Postal Service is excluded from the private-employer guidance section.
- Coverage: The federal mandate explicitly includes the Veterans Health Administration.
- Nature of requirements: Guidance for private employers is voluntary; federal agencies would be required to comply.
Who’s For It
- Sponsors: Sens. Jeff Merkley (D-OR), Lisa Murkowski (R-AK), Martin Heinrich (D-NM), Adam Schiff (D-CA), and Ron Wyden (D-OR) back the bill, framing it as a practical step to save lives during the opioid crisis.
- Likely supporters: Many public-health and harm-reduction advocates tend to support wider access to overdose-reversal medication and training, viewing workplaces as another place where quick action can prevent deaths.
Who’s Against It
- No formal opposition named in the bill text or actions so far.
- Potential concerns that may surface: costs and logistics for stocking and maintaining medication; questions about liability and training quality; skepticism about creating a new federal mandate for agencies; and whether workplaces (especially low-risk settings) should be part of overdose response.
What’s Next
Status as of March 20, 2026: S. 3812 was introduced on February 10, 2026, referred to the Senate Health, Education, Labor, and Pensions (HELP) Committee, and the committee held a hearing on March 19, 2026. The bill currently remains in the HELP Committee; it would need a committee vote, then full Senate consideration, and action by the House before it could become law.
Discussion